TB Alliance moves two novel tuberculosis drugs into human trials
(Burness) TBA-7371 and sutezolid entered phase 1 clinical trials, TB Alliance announced today. Both compounds have proceeded through early preclinical development and were granted 'Investigative New Drug' status by the US Food and Drug Administration. The phase 1 clinical trials are presently ongoing.
Source: EurekAlert! - Infectious and Emerging Diseases - Category: Infectious Diseases Source Type: news
More News: Clinical Trials | Food and Drug Administration (FDA) | Infectious Diseases | Tuberculosis